EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Topical metformin 30% gel in the treatment of acne vulgaris in women, a split face, placebo‐controlled study

Mohamed H M El-Komy, Nesma Moustafa Kamel Abdo, Rehab Nabil Shamma, Nermeen Ibrahim Bedair iD

Experimental Dermatology · 2023

DOI: 10.1111/exd.14868 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Experimental Dermatology, 2023. Verfasst von Mohamed H M El-Komy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Faculty of Medicine, Cairo University, Cairo, Egypt. Hauptthemen laut MEDLINE: Acne Vulgaris, Dermatitis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acne vulgaris (AV), a widely common disorder, that negatively affects the quality of life. Metformin is a relatively safe, cheap and well tolerated drug that is widely used in the treatment of Diabetes. Systemic metformin has demonstrated promising results in treating acne, while topically it was studied for melasma and recalcitrant central centrifugal cicatricial alopecia. To study the safety and efficacy of topical metformin 30% in the treatment of AV. Twenty‐seven female AV patients were asked to blindly apply metformin and placebo gels to either side of the face for 12 weeks. AV lesion count was performed at baseline, at each visit and 4 weeks after end of treatment. At the end of the treatment period, the treated side showed significant improvement of comedones, papules and nodules but not pustules. Although, lesions count increased 1 month after stopping treatment, comedones and papules numbers were still significantly less on the metformin side compared to placebo. No side effects were reported. The limited number of patients studied and the limited follow‐up period. The metformin effect was not studied on cellular and molecular levels. Topical metformin nanoemulsion gel can be a promising safe and effective treatment of AV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acne VulgarisDermatitisHumansFemaleQuality of LifeTreatment OutcomeGels

Stichwörter der Autor:innen

acnecomedonesinflammatory acnemetformin

Substanzen

Gels

Autor:innen und Institutionen

  • Department of Dermatology, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Department of Dermatology, National Hepatology and Tropical Medicine Institute, Cairo, Egypt.
  • Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
  • Department of Dermatology, Andrology, Sexual Medicine and STDs, Faculty of Medicine, Helwan University, Helwan, Egypt.

ORCID-Profile: Nermeen Ibrahim Bedair

Zitieren

APA

El-Komy, M. H. M., Abdo, N. M. K., Shamma, R. N., & Bedair, N. I. (2023). Topical metformin 30% gel in the treatment of acne vulgaris in women, a split face, placebo‐controlled study. Experimental Dermatology. https://doi.org/10.1111/exd.14868

Vancouver

El-Komy MHM, Abdo NMK, Shamma RN, Bedair NI. Topical metformin 30% gel in the treatment of acne vulgaris in women, a split face, placebo‐controlled study. Experimental Dermatology. 2023. doi:10.1111/exd.14868

BibTeX
@article{ElKomy2023,
  author = {El-Komy, Mohamed H M and Abdo, Nesma Moustafa Kamel and Shamma, Rehab Nabil and Bedair, Nermeen Ibrahim},
  title = {Topical metformin 30% gel in the treatment of acne vulgaris in women, a split face, placebo‐controlled study},
  journal = {Experimental Dermatology},
  year = {2023},
  doi = {10.1111/exd.14868}
}
Kostenlos starten →